Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 FY- Text added to 2020 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
alongside, Alvotech, anesthesiologist, Antitrust, atezolizumab, attack, avelumab, Bausch, Bavencio, BeiGene, Biden, BMS, Bond, Breakthrough, built, Canadian, certified, checkpoint, Chinese, CJEU, covenant, CPRA, cybersecurity, deferral, depression, destination, display, durvalumab, EMD, engineered, engineering, erroneously, exhaust, Fast, fifteen, GlaxoSmithKline, governor, Hedge, Hedging, hoping, HSR, Imfinzi, implicit, inappropriate, incentivizing, indenture, inhibitor, Interactive, Junshi, Justice, Keytruda, kill, Kimberly, Libtayo, Likewise, Lomb, malware, mammalian, Mark, melanoma, Mendelson, mission, mucosal, Mundipharma, nasopharyngeal, NHSA, nivolumab, NMPA, nonbifurcation, NRDL, nurse, online, Onpro, Opdivo, overstated, pandemic, payroll, pembrolizumab, phishing, PPQ, Pub, quarantining, ransomware, realignment, recession, regular, remotely, reproduce, rescinded, resume, resumption, risky, Rodino, ROU, Sanofi, sarcoma, Schema, Serono, server, Shanghai, Shield, social, soft, spam, Squibb, Stat, Stolper, strain, strained, strike, subordinated, sudden, Tecentriq, Therapy, thirty, toripalimab, toripalimb, UDENCYA, udenyca®, unavailable, undisclosed, unresectable, unsecured, upholding, urothelial, vacation, vehicle, vulnerable, weather, widespread, withdrew, Wuhan
Removed:
accruing, acid, activation, allocate, alpha, amino, assumed, assured, Barbara, base, beta, chemical, Codification, comparative, considerable, constituting, contractually, CRL, Daiichi, deliverable, deployed, determinable, disadvantage, discernable, division, dose, Dr, ErelziTM, expended, expiring, explanation, extracellular, fatty, Fc, FDCA, Finck, Formycon, fused, gamma, Immunex, immunoglobulin, improvement, invalidation, IQVIA, Japanese, Kirin, Kyowa, leasing, leukemia, liver, mediated, memoranda, Memorandum, MEN, mg, Mine, Momenta, MOU, Neupogen, notified, overestimate, peroxisome, persuasive, Peter, placebo, postponement, PPACA, presently, prioritized, proportion, PTAB, purpose, Qualitative, Quantitative, randomized, reflecting, regained, regularly, relapsing, released, remitting, represented, retained, retrospective, revised, ruling, Sankyo, sequence, sixty, South, spectrum, supplied, suppression, Taiwan, tenant, top, transparent, unaudited, undelivered, underestimate, understand, uneven, unexpired, Unresolved, Watler, weakened, web, WOMEN, workforce
Valuein 2019 FY filing- Value in 2020 FY filing
Original filings
Filing view